Distinct Worst Pain Profiles in Oncology Outpatients Undergoing Chemotherapy
- PMID: 35439202
- PMCID: PMC9554042
- DOI: 10.1097/NCC.0000000000001095
Distinct Worst Pain Profiles in Oncology Outpatients Undergoing Chemotherapy
Abstract
Background: While pain is a significant problem for oncology patients, little is known about interindividual variability in pain characteristics.
Objective: The aims of this study were to identify subgroups of patients with distinct worst pain severity profiles and evaluate for differences among these subgroups in demographic, clinical, and pain characteristics and stress and symptom scores.
Methods: Patients (n = 934) completed questionnaires 6 times over 2 chemotherapy cycles. Worst pain intensity was assessed using a 0- to 10-point numeric rating scale. Brief Pain Inventory was used to assess various pain characteristics. Latent profile analysis was used to identify subgroups of patients with distinct pain profiles.
Results: Three worst pain profiles were identified (low [17.5%], moderate [39.9%], severe [42.6%]). Compared with the other 2 classes, severe class was more likely to be single and unemployed and had a lower annual household income, a higher body mass index, a higher level of comorbidity, and a poorer functional status. Severe class was more likely to have both cancer and noncancer pain, a higher number of pain locations, higher frequency and duration of pain, worse pain quality scores, and higher pain interference scores. Compared with the other 2 classes, severe class reported lower satisfaction with pain management and higher global, disease-specific, and cumulative life stress, as well as higher anxiety, depression, fatigue, sleep disturbance, and cognitive dysfunction scores.
Conclusions: Unrelieved pain is a significant problem for more than 80% of outpatients.
Implications for practice: Clinicians need to perform comprehensive pain assessments; prescribe pharmacologic and nonpharmacologic interventions; and initiate referrals for pain management and psychological services.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Worst Pain Severity Profiles of Oncology Patients Are Associated With Significant Stress and Multiple Co-Occurring Symptoms.J Pain. 2022 Jan;23(1):74-88. doi: 10.1016/j.jpain.2021.07.001. Epub 2021 Jul 21. J Pain. 2022. PMID: 34298161 Free PMC article.
-
Impact of worst pain severity and morning fatigue profiles on oncology outpatients' symptom burden and quality of life.Support Care Cancer. 2022 Dec;30(12):9929-9944. doi: 10.1007/s00520-022-07431-6. Epub 2022 Nov 10. Support Care Cancer. 2022. PMID: 36355215
-
Exploration of the Relationships Between Stress and Distinct Pain and Sleep Disturbance Profiles in Patients Undergoing Chemotherapy.Cancer Nurs. 2024 Mar-Apr 01;47(2):E108-E122. doi: 10.1097/NCC.0000000000001185. Epub 2023 Jan 4. Cancer Nurs. 2024. PMID: 36584234 Free PMC article.
-
Distinct Wound Healing and Quality-of-Life Outcomes in Subgroups of Patients With Venous Leg Ulcers With Different Symptom Cluster Experiences.J Pain Symptom Manage. 2017 May;53(5):871-879. doi: 10.1016/j.jpainsymman.2016.12.336. Epub 2017 Jan 4. J Pain Symptom Manage. 2017. PMID: 28063868 Review.
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
Cited by
-
Targeting TRPV4 Channels for Cancer Pain Relief.Cancers (Basel). 2024 Apr 27;16(9):1703. doi: 10.3390/cancers16091703. Cancers (Basel). 2024. PMID: 38730655 Free PMC article. Review.
-
Short course palliative radiotherapy in advanced solid tumors: a pooled analysis (the SHARON project).Sci Rep. 2022 Dec 5;12(1):20978. doi: 10.1038/s41598-022-25602-7. Sci Rep. 2022. PMID: 36471159 Free PMC article.
References
-
- van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070–1090 e1079. - PubMed
-
- Miltenburg NC, Boogerd W. Chemotherapy-induced neuropathy: A comprehensive survey. Cancer Treat Rev. 2014;40(7):872–882. - PubMed
-
- Langford DJ, Paul SM, Cooper B, et al. Comparison of subgroups of breast cancer patients on pain and co-occurring symptoms following chemotherapy. Support Care Cancer. 2016;24(2):605–614. - PubMed
-
- Bonhof CS, Trompetter HR, Vreugdenhil G, van de Poll-Franse LV, Mols F. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry. Support Care Cancer. 2020;28(12):5933–5941. - PMC - PubMed